Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Michael Schotsaert

Awards & Distinctions

21 Results

2022

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Teodora-Eugenia OlteanLorena IbanezTatyana DivertTine YsenbaertHannelore Van EeckhoutteVera GoossensMichael SchotsaertKen BrackeBert SchepensJonathan Maelfait et al.

A1 Journal Article in CELL DEATH & DISEASE

2018

Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza

Emma JobMichael SchotsaertLorena IbanezAnouk SmetTine YsenbaertKenny RooseM. DaiC. A. M. de HaanH. KleanthousT. U. Vogel et al.

A1 Journal Article in JOURNAL OF VIROLOGY

2017

Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies

Silvie Van den HoeckeKatrin EhrhardtAnnasaheb KolpeKarim El BakkouriLei DengHendrik GrootaertSteve SchoonoogheAnouk SmetMostafa BentahirKenny Roose et al.

A1 Journal Article in JOURNAL OF VIROLOGY

2016

Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination

Zhiyue ZhangBert SchepensLutz NuhnXavier SaelensMichael SchotsaertNico CallewaertRiet De RyckeQilu ZhangSébastien MoinsSamira Benali et al.

A1 Journal Article in CHEMICAL COMMUNICATIONS

2015

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

Sarah De BaetsJudith VerhelstSilvie Van den HoeckeAnouk SmetMichael SchotsaertEmma JobKenny RooseBert SchepensWalther FiersXavier Saelens

A1 Journal Article in PLOS ONE

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen

Bert SchepensMichael SchotsaertXavier Saelens

Editorial material

2014

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

Bert SchepensKoen SedeynLiesbeth Vande GinsteSarah De BaetsMichael SchotsaertKenny RooseLieselot HouspieMarc Van RanstBarbara GilbertNico van Rooijen et al.

A1 Journal Article in EMBO MOLECULAR MEDICINE

2013

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A

Lorena IbanezKenny RooseMarina De FiletteMichael SchotsaertJessica De SloovereStefan RoelsCharlotte PollardBert SchepensJohan GrootenWalther Fiers et al.

A1 Journal Article in PLOS ONE

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

Michael SchotsaertTine YsenbaertKristien NeytsLorena IbanezPieter BogaertBert SchepensBart LambrechtWalther FiersXavier Saelens

A1 Journal Article in MUCOSAL IMMUNOLOGY

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

Sarah De BaetsBert SchepensKoen SedeynMichael SchotsaertKenny RoosePieter BogaertWalther FiersXavier Saelens

A1 Journal Article in JOURNAL OF VIROLOGY

2012

Cutting edge approaches towards novel and cross-protective influenza vaccines

Kenny RooseMichael SchotsaertKarim El BakkouriBert SchepensWalther FiersXavier Saelens

Bookchapter in Development of novel vaccines : skills, knowledge and translational technologies

Influenza vaccines: T-cell responses deserve more attention

Michael SchotsaertXavier SaelensGeert Leroux-Roels

A1 Journal Article in EXPERT REVIEW OF VACCINES

2011

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective

Marina De FiletteTine YsenbaertKenny RooseMichael SchotsaertStefan RoelsEls GoossensBert SchepensWalther FiersXavier Saelens

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

Modulation of humoral and cellular immunity to influenza by vaccination

Michael SchotsaertXavier Saelens

2010

Controlling influenza by cytotoxic T-cells : calling for help from destroyers

Michael SchotsaertLorena IbanezWalther FiersXavier Saelens

A1 Journal Article in JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

2009

M2e-based universal influenza A vaccine

Walther FiersMarina De FiletteKarim El BakkouriBert SchepensKenny RooseMichael SchotsaertA BirkettXavier Saelens

A1 Journal Article in VACCINE

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine

Delphine CouckeMichael SchotsaertClaude LibertEveline PringelsChris VervaetP ForemanXavier SaelensJean Paul Remon

A1 Journal Article in Vaccine

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

Michael SchotsaertMarina De FiletteWalther FiersXavier Saelens

A1 Journal Article in EXPERT REVIEW OF VACCINES

2008

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

Marina De FiletteWouter MartensAnouk SmetMichael SchotsaertAshley BirkettPatricia Londoño-ArcilaWalther FiersXavier Saelens

A1 Journal Article in Vaccine

Vaccine development by recombinant DNA technology. Part I: DNA Vaccines

Amin BredanKenny RooseMichael SchotsaertXavier Saelens

Bookchapter in The Oea Review of Medicine

Vaccine development by recombinant DNA technology. Part II: Virus-like Particles

Amin BredanKenny RooseMichael SchotsaertXavier Saelens

Bookchapter in The Oea Review of Medicine